tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jennifer Kim, 47 are a BUY (97.92%), 1 are a HOLD (2.08%).
Analyst Jennifer Kim, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 23.33% that have a potential upside of 34.07% achieved within 170 days.
Jennifer Kim’s has documented 77 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 21-Feb-2025.
Analyst best performing recommendations are on BLTE (BELITE BIO ADR).
The best stock recommendation documented was for ALLK (ALLAKOS) at 9/12/2022. The price target of $7 was fulfilled within 57 days with a profit of $1.94 (38.34%) receiving and performance score of 6.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$7
$3.87 (123.64%)
$8
2 months 6 days ago
(16-Dec-2024)
1/4 (25%)
$3.61 (106.49%)
187
Buy
$20
2 months 6 days ago
(16-Dec-2024)
0/3 (0%)
$15.92 (390.20%)
Buy
1 years 6 months 7 days ago
(15-Aug-2023)
0/2 (0%)
$8.34 (125.23%)
Which stock is Jennifer Kim is most bullish on?
What Year was the first public recommendation made by Jennifer Kim?
